373 studies found for:
Open Studies | "Sarcoma"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
|
||||
| 2 | Recruiting |
Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas
|
||||
| 3 | Recruiting |
Alisertib in Treating Patients With Advanced or Metastatic Sarcoma
|
||||
| 4 | Recruiting |
Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma
|
||||
| 5 | Recruiting |
Dendritic Cell Vaccine With or Without Gemcitabine Pre-Treatment for Adults and Children With Sarcoma
|
||||
| 6 | Recruiting |
Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma
|
||||
| 7 | Recruiting |
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
|
||||
| 8 | Not yet recruiting |
Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma
|
||||
| 9 | Recruiting |
Pazopanib Hydrochloride Followed By Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma
|
||||
| 10 | Recruiting |
Autologous T Cells and Cyclophosphamide in Treating Patients With Soft Tissue Sarcoma That is Metastatic or Cannot Be Removed By Surgery
|
||||
| 11 | Recruiting |
18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma
|
||||
| 12 | Recruiting |
Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot be Removed by Surgery or Are Metastatic
|
||||
| 13 | Recruiting |
A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas
|
||||
| 14 | Recruiting |
Mithramycin for Children and Adults With Solid Tumors or Ewing Sarcoma
|
||||
| 15 | Recruiting |
Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma
|
||||
| 16 | Recruiting |
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
|
||||
| 17 | Unknown † |
Bevacizumab and Radiation Therapy for Sarcomas
|
||||
| 18 | Recruiting |
Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
|
||||
| 19 | Recruiting |
Continuing vs Intermittent Trabectedin-regimen in Patients With Advanced Soft Tissue Sarcoma Experiencing Response or Stable Disease After the 6th Cycle
|
||||
| 20 | Recruiting |
Proton Radiation for the Treatment of Pediatric Bone and Non-Rhabdomyosarcoma Soft Tissue Sarcomas
|
† Indicates status has not been verified in more than two years
